Drugs Made In America Acquisition (DMAA) Non Operating Income (2025)
Drugs Made In America Acquisition filings provide 1 years of Non Operating Income readings, the most recent being $2.3 million for Q4 2025.
Drugs Made In America Acquisition filings provide 1 years of Non Operating Income readings, the most recent being $2.3 million for Q4 2025.
| Date | Value |
|---|---|
Offer Ends In
Starting from $49 $19 / month